Literature DB >> 9283515

Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris.

C L Donovan1, K P Landolfo, J E Lowe, F Clements, R B Coleman, T Ryan.   

Abstract

OBJECTIVES: The purpose of this ongoing study is to determine whether transmyocardial laser revascularization (TMLR) can lessen inducible ischemia and improve contractile reserve in patients with refractory angina pectoris.
BACKGROUND: TMLR is an emerging surgical technique for the treatment of myocardial ischemia and angina pectoris not amenable to conventional percutaneous or surgical revascularization. Objective data documentating a reduction in ischemia during noninvasive stress testing after TMLR are rare.
METHODS: Fifteen patients with severe coronary artery disease unsuitable for treatment with standard revascularization techniques were studied with dobutamine stress echocardiography (DSE) before TMLR. Of the 12 patients who underwent TMLR, DSE was repeated at 3 months postoperatively in 11 patients and at 6 months in 9 patients. Stress echocardiograms were analyzed for inducible ischemia, with calculation of the wall motion score index (WMSI). Heart rate and dobutamine dose achieved at peak stress were also assessed as indexes of stress tolerance.
RESULTS: Compared with that before TMLR, wall motion at rest for all myocardial segments did not change significantly after TMLR, although there was a mild improvement in the WMSI of the lased myocardial regions ([mean +/- SD] 1.64 +/- 0.34 after vs. 1.78 +/- 0.34 before TMLR, p < 0.05). Overall WMSI at peak stress improved markedly after TMLR (1.70 +/- 0.30 after vs. 2.06 +/- 0.31 before TMLR, p < 0.002), with the improvement in WMSI limited to the lased segments only (1.47 +/- 0.31 after vs. 2.15 +/- 0.34 before TMLR, p < 0.0004). The improvement in WMSI with stress resulted primarily from a decrease in the percentage of ischemic segments (47% before vs. 23% after TMLR, p < 0.0008), with no change in the percentage of infarcted segments (23% before vs. 26% after TMLR). Heart rate (83 +/- 5 beats/min before vs. 102 +/- 21 beats/min after TMLR, p = 0.01) and dobutamine infusion rate (26 +/- 9 micrograms/kg body weight per min before vs. 34 +/- 9 micrograms/kg per min after TMLR) achieved at peak stress also increased postoperatively, consistent with improved stress tolerance. The reduction in ischemic wall motion abnormalities and improved stress tolerance persisted at 6 months, without evidence of further improvement or deterioration of function over time.
CONCLUSIONS: TMLR performed in patients with refractory angina pectoris reduces ischemic wall motion abnormalities and improves stress-induced tolerance during dobutamine echocardiography. These beneficial effects persist up to 6 months postoperatively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283515     DOI: 10.1016/s0735-1097(97)00219-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Percutaneous Myocardial Revascularization.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

2.  Does laser injury induce a different neovascularisation pattern from mechanical or ischaemic injuries?

Authors:  X M Mueller; H T Tevaearai; P Chaubert; C Y Genton; L K von Segesser
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

3.  The prospective clinical and scintigraphic assessment of patients with preserved left ventricular systolic function after transmyocardial laser revascularisation.

Authors:  Miroslaw A Dziuk; Ana Canizales; Nidhal Ali; Hany El-Deeb; Keith E Britton; Duncan S Dymond; Stephen J Edmondson
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

4.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

Review 5.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

Review 6.  Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease?

Authors:  O H Frazier; K A Kadipasaoglu; D A Cooley
Journal:  Tex Heart Inst J       Date:  1998

7.  [Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center].

Authors:  Melanie Gatterer; Mariann Gyöngyösi; Wolfgang Sperker; Christoph Strehblow; Aliasghar Khorsand; Senta Graf; Heinz Sochor; Dietmar Glogar
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

Review 8.  Transmyocardial revascularization devices: technology update.

Authors:  Bogdan A Kindzelski; Yifu Zhou; Keith A Horvath
Journal:  Med Devices (Auckl)       Date:  2014-12-18

Review 9.  Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.

Authors:  Jessika Iwanski; Shannon M Knapp; Ryan Avery; Isabel Oliva; Raymond K Wong; Raymond B Runyan; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.